515 related articles for article (PubMed ID: 9264011)
1. Mutation (677 C to T) in the methylenetetrahydrofolate reductase gene aggravates hyperhomocysteinemia in hemodialysis patients.
Födinger M; Mannhalter C; Wölfl G; Pabinger I; Müller E; Schmid R; Hörl WH; Sunder-Plassmann G
Kidney Int; 1997 Aug; 52(2):517-23. PubMed ID: 9264011
[TBL] [Abstract][Full Text] [Related]
2. The role of vitamin B12 in fasting hyperhomocysteinemia and its interaction with the homozygous C677T mutation of the methylenetetrahydrofolate reductase (MTHFR) gene. A case-control study of patients with early-onset thrombotic events.
D'Angelo A; Coppola A; Madonna P; Fermo I; Pagano A; Mazzola G; Galli L; Cerbone AM
Thromb Haemost; 2000 Apr; 83(4):563-70. PubMed ID: 10780318
[TBL] [Abstract][Full Text] [Related]
3. Methylenetetrahydrofolate reductase genotype, vitamin B12, and folate influence plasma homocysteine in hemodialysis patients.
Nakamura T; Saionji K; Hiejima Y; Hirayama H; Tago K; Takano H; Tajiri M; Hayashi K; Kawabata M; Funamizu M; Makita Y; Hata A
Am J Kidney Dis; 2002 May; 39(5):1032-9. PubMed ID: 11979347
[TBL] [Abstract][Full Text] [Related]
4. [Methylenetetrahydrofolate reductase gene polymorphism and plasma homocysteine levels in hemodialysing patients].
Yao Y; Liu H; Zhang X; Duan X
Zhonghua Nei Ke Za Zhi; 2002 Aug; 41(8):522-5. PubMed ID: 12421498
[TBL] [Abstract][Full Text] [Related]
5. Determinants of fasting and post-methionine homocysteine levels in families predisposed to hyperhomocysteinemia and premature vascular disease.
de Jong SC; Stehouwer CD; van den Berg M; Kostense PJ; Alders D; Jakobs C; Pals G; Rauwerda JA
Arterioscler Thromb Vasc Biol; 1999 May; 19(5):1316-24. PubMed ID: 10323785
[TBL] [Abstract][Full Text] [Related]
6. Plasma folate, vitamin B(12), and total homocysteine and homozygosity for the C677T mutation of the 5,10-methylene tetrahydrofolate reductase gene in patients with Alzheimer's dementia. A case-control study.
Postiglione A; Milan G; Ruocco A; Gallotta G; Guiotto G; Di Minno G
Gerontology; 2001; 47(6):324-9. PubMed ID: 11721146
[TBL] [Abstract][Full Text] [Related]
7. Effect of MTHFR 677C>T on plasma total homocysteine levels in renal graft recipients.
Födinger M; Wölfl G; Fischer G; Rasoul-Rockenschaub S; Schmid R; Hörl WH; Sunder-Plassmann G
Kidney Int; 1999 Mar; 55(3):1072-80. PubMed ID: 10027946
[TBL] [Abstract][Full Text] [Related]
8. Hyperhomocysteinemia is related to residual glomerular filtration and folate, but not to methylenetetrahydrofolate-reductase and methionine synthase polymorphisms, in supplemented end-stage renal disease patients undergoing hemodialysis.
Anwar W; Guéant JL; Abdelmouttaleb I; Adjalla C; Gérard P; Lemoel G; Erraess N; Moutabarrek A; Namour F
Clin Chem Lab Med; 2001 Aug; 39(8):747-52. PubMed ID: 11592445
[TBL] [Abstract][Full Text] [Related]
9. Association of two MTHFR polymorphisms with total homocysteine plasma levels in dialysis patients.
Födinger M; Buchmayer H; Heinz G; Papagiannopoulos M; Kletzmayr J; Perschl A; Vychytil A; Hörl WH; Sunder-Plassmann G
Am J Kidney Dis; 2001 Jul; 38(1):77-84. PubMed ID: 11431185
[TBL] [Abstract][Full Text] [Related]
10. Effect of MTHFR 1298A-->C and MTHFR 677C-->T genotypes on total homocysteine, folate, and vitamin B(12) plasma concentrations in kdiney graft recipients.
Födinger M; Buchmayer H; Heinz G; Papagiannopoulos M; Kletzmayr J; Rasoul-Rockenschaub S; Hörl WH; Sunder-Plassmann G
J Am Soc Nephrol; 2000 Oct; 11(10):1918-1925. PubMed ID: 11004224
[TBL] [Abstract][Full Text] [Related]
11. Hyperhomocysteinaemia, folate and vitamin B12 in unsupplemented haemodialysis patients: effect of oral therapy with folic acid and vitamin B12.
Billion S; Tribout B; Cadet E; Queinnec C; Rochette J; Wheatley P; Bataille P
Nephrol Dial Transplant; 2002 Mar; 17(3):455-61. PubMed ID: 11865092
[TBL] [Abstract][Full Text] [Related]
12. [Some aspects of homocysteine metabolism in hemodialysis patients].
Bednarek-Skublewska A; Buraczyńska M; Wawrzycki S; Baranowicz-Gaszczyk I; Ksiazek A
Pol Arch Med Wewn; 2002 Nov; 108(5):1041-7. PubMed ID: 12685244
[TBL] [Abstract][Full Text] [Related]
13. Hyperhomocysteinemia but not the C677T mutation of methylenetetrahydrofolate reductase is an independent risk determinant of carotid wall thickening. The Perth Carotid Ultrasound Disease Assessment Study (CUDAS).
McQuillan BM; Beilby JP; Nidorf M; Thompson PL; Hung J
Circulation; 1999 May; 99(18):2383-8. PubMed ID: 10318658
[TBL] [Abstract][Full Text] [Related]
14. Genetic and nongenetic factors influencing plasma homocysteine levels in patients with ischemic cerebrovascular disease and in healthy control subjects.
Lalouschek W; Aull S; Serles W; Schnider P; Mannhalter C; Lang T; Deecke L; Zeiler K
J Lab Clin Med; 1999 Jun; 133(6):575-82. PubMed ID: 10360632
[TBL] [Abstract][Full Text] [Related]
15. Polymorphism in methylenetetrahydrofolate reductase gene: its impact on plasma homocysteine levels and carotid atherosclerosis in ESRD patients receiving hemodialysis.
Lim PS; Hung WR; Wei YH
Nephron; 2001 Mar; 87(3):249-56. PubMed ID: 11287760
[TBL] [Abstract][Full Text] [Related]
16. [Frequency of hyperhomocysteinemia in hemodialysis patients with folic acid supplementation].
Kárpáti I; Balla J; Szóke G; Bereczky Z; Páll D; Ben T; Toma K; Katona E; Mohácsi A; Paragh G; Varga Z; Kakuk G; Muszbek L
Orv Hetil; 2002 Jul; 143(27):1635-40. PubMed ID: 12180000
[TBL] [Abstract][Full Text] [Related]
17. Influence of 5,10-methylenetetrahydrofolate reductase gene polymorphism on plasma homocysteine concentration in patients with end-stage renal disease.
Lee HA; Choi JS; Ha KS; Yang DH; Chang SK; Hong SY
Am J Kidney Dis; 1999 Aug; 34(2):259-63. PubMed ID: 10430972
[TBL] [Abstract][Full Text] [Related]
18. The effect of a common methylenetetrahydrofolate reductase mutation on levels of homocysteine, folate, vitamin B12 and on the risk of premature atherosclerosis.
Verhoeff BJ; Trip MD; Prins MH; Kastelein JJ; Reitsma PH
Atherosclerosis; 1998 Nov; 141(1):161-6. PubMed ID: 9863549
[TBL] [Abstract][Full Text] [Related]
19. Hyperhomocysteinemia in hemodialysis patients: effects of 12-month supplementation with hydrosoluble vitamins.
Tremblay R; Bonnardeaux A; Geadah D; Busque L; Lebrun M; Ouimet D; Leblanc M
Kidney Int; 2000 Aug; 58(2):851-8. PubMed ID: 10916110
[TBL] [Abstract][Full Text] [Related]
20. Vitamin B12 decreases, but does not normalize, homocysteine and methylmalonic acid in end-stage renal disease: a link with glycine metabolism and possible explanation of hyperhomocysteinemia in end-stage renal disease.
Hyndman ME; Manns BJ; Snyder FF; Bridge PJ; Scott-Douglas NW; Fung E; Parsons HG
Metabolism; 2003 Feb; 52(2):168-72. PubMed ID: 12601627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]